|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tetryl | CAS 479-45-8 | ||
| (NO2)3C6H2N(NO2)CH3 | RTECS BY6300000 | ||
|
Synonyms & Trade Names N-Methyl-N,2,4,6-tetranitroaniline; Nitramine; 2,4,6-Tetryl; 2,4,6-Trinitrophenyl-N-methylnitramine |
DOT ID & Guide |
||
|
Exposure Limits |
NIOSH REL: TWA 1.5 mg/m3 [skin] | ||
| OSHA PEL: TWA 1.5 mg/m3 [skin] | |||
| IDLH 750 mg/m3 See: 479458 | Conversion | ||
|
Physical Description Colorless to yellow, odorless, crystalline solid. |
|||
|
MW: 287.2 |
BP: 356-374°F (Explodes) |
MLT: 268°F |
Sol: 0.02% |
|
VP: <1 mmHg |
IP: ? |
|
Sp.Gr: 1.57 |
|
Fl.P: Explodes |
UEL: ? |
LEL: ? |
|
| Combustible Solid (Class A Explosive) | |||
|
Incompatibilities & Reactivities Oxidizable materials, hydrazine |
|||
|
Measurement Methods NIOSH S225 (II-3) See: NMAM or OSHA Methods |
|
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated/Daily Remove: When wet or contaminated Change: Daily |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash promptly Breathing: Respiratory support Swallow: Medical attention immediately |
|
Important additional information about respirator selection Respirator Recommendations NIOSH/OSHA Up to 7.5 mg/m3: (APF = 5) Any dust and mist respirator Up to 15 mg/m3: (APF = 10) Any dust and mist respirator except single-use and quarter-mask respirators*/(APF = 10) Any supplied-air respirator* Up to 37.5 mg/m3: (APF = 25) Any supplied-air respirator operated in a continuous-flow mode*/(APF = 25) Any powered, air-purifying respirator with a dust and mist filter* Up to 75 mg/m3: (APF = 50) Any air-purifying, full-facepiece respirator with a high-efficiency particulate filter/(APF = 50) Any self-contained breathing apparatus with a full facepiece/(APF = 50) Any supplied-air respirator with a full facepiece Up to 750 mg/m3: (APF = 2000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode Emergency or planned entry into unknown concentrations or IDLH conditions: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator with a high-efficiency particulate filter/Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Sensitization dermatitis, itch, erythema (skin redness); edema on nasal folds, cheeks, neck; keratitis (inflammation of the cornea); sneezing; anemia; cough, coryza; irritability; malaise (vague feeling of discomfort), headache, lassitude (weakness, exhaustion), insomnia; nausea, vomiting; liver, kidney damage | |
|
Target Organs
Eyes, skin, respiratory system, central nervous system, liver, kidneys |
|
| See also: INTRODUCTION See ICSC CARD: 0959 See MEDICAL TESTS: 0227 |